Improvement in endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus.

[1]  C. Manso,et al.  Angiotensin converting enzyme inhibitors as oxygen free radical scavengers. , 1993, Free radical research communications.

[2]  S. Moncada,et al.  Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. , 1992, Journal of hypertension.

[3]  G. Levine,et al.  Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. , 1996, Circulation.

[4]  Farris K. Timimi,et al.  Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. , 1996, The Journal of clinical investigation.

[5]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[6]  D. Green,et al.  The HMG-CoA reductase inhibitor, simvastatin, improves endothelial function within one month , 1997 .

[7]  C. Cobelli,et al.  Forearm Nitric Oxide Balance, Vascular Relaxation, and Glucose Metabolism in NIDDM Patients , 1997, Diabetes.

[8]  P. Vanhoutte,et al.  Endothelium-derived relaxing factors and converting enzyme inhibition. , 1995, The American journal of cardiology.

[9]  D. Spiegelhalter,et al.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.

[10]  A. Chait,et al.  Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway. , 1994, The Journal of clinical investigation.

[11]  O. Carretero,et al.  Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. , 1992, Biochemical and biophysical research communications.

[12]  B. Blanksby,et al.  Lack of effect of vitamin E administration on basal nitric oxide function in male smokers and non-smokers. , 1995, Clinical science.

[13]  G. Pieper Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. , 1997, Journal of cardiovascular pharmacology.

[14]  H. Dargie,et al.  The effect of angiotensin-converting enzyme inhibitors on human neutrophil chemotaxis in vitro. , 1994, British journal of clinical pharmacology.

[15]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1993 .

[16]  D. Harrison,et al.  Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. , 1996, The Journal of clinical investigation.

[17]  D. Harrison,et al.  Reversing endothelial dysfunction with ACE inhibitors. A new trend. , 1996, Circulation.

[18]  D. Green,et al.  Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month. , 1997, Circulation.

[19]  R. Cohen,et al.  Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. , 1990, The Journal of clinical investigation.

[20]  M. Creager,et al.  -.____----.---_-Impaired Nitric Oxide-Mediated Vasodilation in Patients With Non-Insulin-Dependent Diabetes Mellitw , 2016 .

[21]  M. Kaufman Comparison of the Free Radical‐scavenging Ability of Captopril and Ascorbic Acid in an In‐vitro Model of Lipid Oxidation. Implications for Reperfusion Injury and ACE Inhibitor Therapy , 1994, The Journal of pharmacy and pharmacology.

[22]  H. Drexler,et al.  Effect of chronic angiotensin-converting enzyme inhibition on endothelial function in patients with chronic heart failure. , 1995, The American journal of cardiology.

[23]  J. Deanfield,et al.  Effect of enalapril on endothelial function in young insulin-dependent diabetic patients: a randomized, double-blind study. , 1998, Journal of the American College of Cardiology.

[24]  H. Parving,et al.  Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy. , 1997, Scandinavian journal of clinical and laboratory investigation.

[25]  P. Vallance,et al.  Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. , 1992, The Journal of clinical investigation.

[26]  D. Celermajer,et al.  Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. , 1994, Journal of the American College of Cardiology.

[27]  J. Hodgson,et al.  Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. , 1994, Journal of the American College of Cardiology.

[28]  B. Blanksby,et al.  Endothelium-derived nitric oxide activity in forearm vessels of tennis players. , 1996, Journal of applied physiology.

[29]  F. Locatelli,et al.  Effect of the Angiotensin-Converting–Enzyme Inhibitor Benazepril on the Progression of Chronic Renal Insufficiency , 1996 .

[30]  J. Kastelein,et al.  Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.

[31]  A. Nitenberg,et al.  Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients. , 1996, Circulation.

[32]  P. Vollenweider,et al.  Nitric oxide release accounts for insulin's vascular effects in humans. , 1994, The Journal of clinical investigation.

[33]  J. Deanfield,et al.  Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. , 1996, The New England journal of medicine.

[34]  K. Emerk,et al.  Protective effects of cilazapril against free radical injury in myocardial ischaemia-reperfusion. , 1995, Pharmacological research.

[35]  P. Smits,et al.  Effect of Long‐Term Angiotensin‐Converting Enzyme Inhibition on Endothelial Function in Patients with the Insulin‐Resistance Syndrome , 1995, Journal of cardiovascular pharmacology.

[36]  J. McGill,et al.  The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.

[37]  A. Takeshita,et al.  Bradykinin-induced vasodilation of human coronary arteries in vivo: role of nitric oxide and angiotensin-converting enzyme. , 1997, Journal of the American College of Cardiology.

[38]  A. Nitenberg,et al.  Impairment of Coronary Vascular Reserve and ACh-Induced Coronary Vasodilation in Diabetic Patients With Angiographically Normal Coronary Arteries and Normal Left Ventricular Systolic Function , 1993, Diabetes.

[39]  R. Bain,et al.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.

[40]  D. Webb,et al.  Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease. , 1996, Circulation.

[41]  Julie H. Campbell,et al.  Perindopril inhibits both the development of atherosclerosis in the cholesterol-fed rabbit and lipoprotein binding to smooth muscle cells in culture. , 1994, Atherosclerosis.

[42]  P. Groop,et al.  Inhibition of nitric oxide synthesis in forearm vasculature of insulin-dependent diabetic patients: blunted vasoconstriction in patients with microalbuminuria. , 1993, Clinical science.

[43]  M. Quon,et al.  Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. , 1996, The Journal of clinical investigation.

[44]  T. Lüscher,et al.  Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. , 1996, Circulation.

[45]  N. Arakawa,et al.  Endothelium-Dependent Vasodilation is Augmented by Angiotensin Converting Enzyme Inhibitors in Healthy Volunteers , 1992, Journal of cardiovascular pharmacology.

[46]  A. Dart,et al.  THERAPEUTIC RESTORATION OF ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLAEMIC SUBJECTS: EFFECT OF FISH OILS , 1994, Clinical and experimental pharmacology & physiology.

[47]  N. Arakawa,et al.  Effect of angiotensin-converting enzyme inhibitors on endothelium-dependent peripheral vasodilation in patients with chronic heart failure. , 1994, Journal of the American College of Cardiology.

[48]  A. Baron,et al.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. , 1996, The Journal of clinical investigation.

[49]  D. Celermajer,et al.  Cigarette Smoking Is Associated With Dose‐Related and Potentially Reversible Impairment of Endothelium‐Dependent Dilation in Healthy Young Adults , 1993, Circulation.

[50]  E. Ferrannini,et al.  Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension. , 1995, Circulation.

[51]  P. Cutler,et al.  Tetrahydrobiopterin metabolism in the streptozotocin induced diabetic state in rats. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[52]  P. Brunetti,et al.  Improved Insulin Action and Glycemic Control After Long Term Angiotensin-Converting Enzyme Inhibition in Subjects with Arterial Hypertension and Type II Diabetes , 1993, Diabetes Care.

[53]  P Vallance,et al.  Measuring forearm blood flow and interpreting the responses to drugs and mediators. , 1995, Hypertension.

[54]  R. Cohen,et al.  Vascular action of the hypoglycaemic agent gliclazide in diabetic rabbits , 1998, Diabetologia.

[55]  L. Groop,et al.  Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. , 1994, JAMA.

[56]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[57]  J. Ritter,et al.  Vascular responsiveness and cation exchange in insulin-dependent diabetes. , 1991, Clinical science.

[58]  S. Andreoli Captopril scavenges hydrogen peroxide and reduces, but does not eliminate, oxidant-induced cell injury. , 1993, The American journal of physiology.

[59]  E. Fleck,et al.  Endothelium-mediated vasodilation during ACE inhibition. , 1995, European heart journal.

[60]  P. Smits,et al.  Endothelium-Dependent Vascular Relaxation in Patients With Type I Diabetes , 1993, Diabetes.

[61]  D. Harrison,et al.  Cellular and molecular mechanisms of endothelial cell dysfunction. , 1997, The Journal of clinical investigation.

[62]  G. Watts,et al.  Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. , 1996, Clinical science.

[63]  G. Watts,et al.  Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia , 1992, The Lancet.

[64]  J. Baynes Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.

[65]  A. Takeshita,et al.  Captopril improves impaired endothelium-dependent vasodilation in hypertensive patients. , 1992, Hypertension.

[66]  J. Deanfield,et al.  Early endothelial dysfunction in adults at risk from atherosclerosis: different responses to L-arginine. , 1998, Journal of the American College of Cardiology.

[67]  F. Locatelli,et al.  Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. , 1996, The New England journal of medicine.

[68]  D. Green,et al.  Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus. , 1997, The Journal of clinical investigation.

[69]  M. Creager,et al.  Impaired Endothelium‐Dependent Vasodilation in Patients With Insulin‐Dependent Diabetes Mellitus , 1993, Circulation.